Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
O.R.S Hydration is a UK-based consumer healthcare brand, owned by Clinova, that specializes in scientifically-formulated oral rehydration therapy. The company's flagship product line consists of soluble tablets that follow the World Health Organization (WHO) guidelines for oral rehydration salts. By utilizing the sodium-glucose co-transport mechanism, these products optimize the absorption of fluids and electrolytes in the digestive tract. O.R.S Hydration targets a diverse consumer base, including professional athletes, travelers, and individuals recovering from illness-related dehydration. The brand has established a global retail presence and maintains high-profile partnerships with major sports organizations. Their portfolio emphasizes portability, stability, and ease of use compared to traditional liquid rehydration solutions.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on O.R.S Hydration.